Invesco’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-294,877
| Closed | -$2.1M | – | 3679 |
|
|
2020
Q1 | $2.1M | Sell |
294,877
-2,323
| -0.8% | -$16.6K | ﹤0.01% | 2360 |
|
|
2019
Q4 | $7.1M | Sell |
297,200
-209,197
| -41% | -$5M | ﹤0.01% | 1948 |
|
|
2019
Q3 | $13.6M | Buy |
506,397
+303,955
| +150% | +$8.15M | ﹤0.01% | 1595 |
|
|
2019
Q2 | $5.49M | Sell |
202,442
-788
| -0.4% | -$21.4K | ﹤0.01% | 2118 |
|
|
2019
Q1 | $7.05M | Buy |
203,230
+10,905
| +6% | +$378K | ﹤0.01% | 1772 |
|
|
2018
Q4 | $3.76M | Buy |
192,325
+352
| +0.2% | +$6.87K | ﹤0.01% | 2105 |
|
|
2018
Q3 | $5.11M | Buy |
191,973
+813
| +0.4% | +$21.6K | ﹤0.01% | 2126 |
|
|
2018
Q2 | $7.22M | Buy |
191,160
+35,221
| +23% | +$1.33M | ﹤0.01% | 1900 |
|
|
2018
Q1 | $5.09M | Buy |
155,939
+15,291
| +11% | +$499K | ﹤0.01% | 1945 |
|
|
2017
Q4 | $6.85M | Sell |
140,648
-8,857
| -6% | -$431K | ﹤0.01% | 1791 |
|
|
2017
Q3 | $8.08M | Buy |
149,505
+4,439
| +3% | +$240K | ﹤0.01% | 1691 |
|
|
2017
Q2 | $8.15M | Buy |
145,066
+78,726
| +119% | +$4.42M | ﹤0.01% | 1672 |
|
|
2017
Q1 | $2.6M | Buy |
+66,340
| New | +$2.6M | ﹤0.01% | 2403 |
|
|
2016
Q4 | – | Sell |
-172,240
| Closed | -$3.91M | – | 3700 |
|
|
2016
Q3 | $3.91M | Buy |
172,240
+24,842
| +17% | +$564K | ﹤0.01% | 2138 |
|
|
2016
Q2 | $3.48M | Buy |
147,398
+45,771
| +45% | +$1.08M | ﹤0.01% | 2151 |
|
|
2016
Q1 | $2.07M | Sell |
101,627
-98,404
| -49% | -$2.01M | ﹤0.01% | 2447 |
|
|
2015
Q4 | $10.3M | Buy |
200,031
+5,189
| +3% | +$267K | ﹤0.01% | 1475 |
|
|
2015
Q3 | $8.3M | Buy |
194,842
+90,055
| +86% | +$3.84M | ﹤0.01% | 1539 |
|
|
2015
Q2 | $4.77M | Buy |
104,787
+564
| +0.5% | +$25.7K | ﹤0.01% | 2026 |
|
|
2015
Q1 | $3.96M | Buy |
104,223
+58,468
| +128% | +$2.22M | ﹤0.01% | 2140 |
|
|
2014
Q4 | $1.3M | Buy |
+45,755
| New | +$1.3M | ﹤0.01% | 2790 |
|